Predictors of persistent symptoms after mRNA SARS-CoV-2 vaccine-related myocarditis (myovacc registry)
AimsEpidemiological surveillance has raised safety concerns for mRNA SARS-CoV-2-vaccination-related myocarditis. We aimed to analyze epidemiological, clinical and imaging findings associated with clinical outcomes in these patients in an international multi-center registry (NCT05268458).Methods and...
Main Authors: | Daniel Schroth, Ria Garg, Xhoi Bocova, Jochen Hansmann, Markus Haass, Andrew Yan, Carlos Fernando, Binita Chacko, Anastasia Oikonomou, James White, Muhammad Mustafa Alhussein, Sorin Giusca, Andreas Ochs, Grigorios Korosoglou, Florian André, Matthias G. Friedrich, Marco Ochs |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1204232/full |
Similar Items
-
Case report: Case series of isolated acute pericarditis after SARS-CoV-2 vaccinations
by: Marco M. Ochs, et al.
Published: (2022-08-01) -
Myocarditis as a cause of neonate’s circulatory failure during delivery - case study
by: Maciej Pękała, et al.
Published: (2023-09-01) -
RHYTHM DISORDERS IN MORPHOLOGICALLY CONFIRMED MYOCARDITIS
by: D. A. Khashchevskaya, et al.
Published: (2015-11-01) -
A growing heart: a literary review on clozapine-induced Myocarditis
by: F. Ramalheira, et al.
Published: (2022-06-01) -
2020 Clinical practice guidelines for Myocarditis in adults
by: G. P. Arutyunov, et al.
Published: (2021-12-01)